Dale E. Sharp
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Diabetes Treatment and Management 3
- Co-authors
- Leo H. Thomas (1 shared paper)Remko A. Bakker (1 shared paper)Rolf Grempler (1 shared paper)Frank Himmelsbach (1 shared paper)Michael Mark (1 shared paper)Matthias Eckhardt (1 shared paper)Thomas Klein (1 shared paper)Peter Eickelmann (1 shared paper)
- Journals
- Xenobiotica (1 paper)The Journal of Organic Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Transfusion (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Dale E. Sharp
12 papers receiving 894 citations
Dale E. Sharp's Hit Papers
Peers
Comparison fields: 5 of 78
- Endocrinology, Diabetes and Metabolism 465
- Neurology 94
- Surgery 222
- Analytical Chemistry 45
- Nephrology 31
Countries citing papers authored by Dale E. Sharp
This map shows the geographic impact of Dale E. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale E. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale E. Sharp more than expected).
Fields of papers citing papers by Dale E. Sharp
This network shows the impact of papers produced by Dale E. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale E. Sharp. The network helps show where Dale E. Sharp may publish in the future.
Co-authors
The 25 scholars most cited alongside Dale E. Sharp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 522 |
| 2 | 1988 | 120 | |
| 3 | 1984 | 47 | |
| 4 | 1998 | 41 | |
| 5 | 1996 | 37 | |
| 6 | 1986 | 29 | |
| 7 | 2014 | 29 | |
| 8 | 2014 | 26 | |
| 9 | 1987 | 26 | |
| 10 | 1990 | 22 | |
| 11 | 1980 | 18 | |
| 12 | 1980 | 18 |
About Dale E. Sharp
Dale E. Sharp is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism, Spectroscopy, Complementary and alternative medicine and Plant Science, having authored 12 papers that have together received 935 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (3 papers), Diabetes Treatment and Management (3 papers), Plant chemical constituents analysis (2 papers), Traditional Chinese Medicine Analysis (2 papers), Parkinson's Disease Mechanisms and Treatments (1 paper), Analytical Methods in Pharmaceuticals (1 paper), Pancreatic function and diabetes (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (465 citations), Neurology (94 citations), Surgery (222 citations), Analytical Chemistry (45 citations) and Nephrology (31 citations). Dale E. Sharp has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Leo H. Thomas, Remko A. Bakker, Rolf Grempler, Frank Himmelsbach, Michael Mark, Matthias Eckhardt, Thomas Klein, Peter Eickelmann, Achim Sauer and Maria Hadjiconstantinou. Their work appears in journals such as Xenobiotica, The Journal of Organic Chemistry, Journal of Pharmacology and Experimental Therapeutics, Transfusion and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.